🔍

HINDUNILVR - Hind. Unilever

📊 NSE: HINDUNILVR 🏢 Personal Care - Multinational 📅 Last Updated: 12/13/2025 23:00

📢 Recent Corporate Announcements

HUL Grants 2,69,514 Stock Options Under Performance Share Plan Scheme 2024

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 16 Mar 2026, 01:00 PM

Hindustan Unilever Limited (HUL) has announced the grant of 2,69,514 stock options to eligible employees under its Performance Share Plan Scheme 2024. The grant was approved by the Nomination and Remuneration Committee via a circular resolution dated March 15, 2026. Although the company stated that this is not a material event under SEBI Regulation 30, the disclosure was made to maintain transparency with shareholders. Such schemes are standard practice in large corporations to align employee performance with long-term shareholder interests.

Grant of 2,69,514 stock options to eligible employees.
Approved under the HUL Performance Share Plan Scheme 2024.
Approval finalized by the Nomination and Remuneration Committee on March 15, 2026.
Company clarified the event is not material under SEBI Listing Obligations but disclosed for transparency.

💡 No action is required as this is a routine administrative disclosure regarding employee compensation and talent retention. Investors should monitor if such grants lead to significant equity dilution over time, though this specific grant is relatively small.

HUL Announces Trading Window Closure from March 16 for FY26 Annual Results

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 13 Mar 2026, 05:42 PM

Hindustan Unilever Limited (HUL) has notified the exchanges regarding the closure of its trading window starting March 16, 2026. This closure is in anticipation of the audited financial results for the quarter and financial year ending March 31, 2026. The restriction applies to designated persons and will lift 48 hours after the results are publicly disclosed. This is a mandatory regulatory requirement under SEBI's Insider Trading guidelines and does not reflect any change in company fundamentals.

Trading window closure begins on March 16, 2026.
Relates to the financial results for the quarter and year ending March 31, 2026.
Window remains closed until 48 hours post-announcement of audited results.
Filing is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

💡 This is a standard procedural announcement with no impact on company fundamentals. Investors should monitor the upcoming earnings date for actual performance data.

HUL to Participate in ICICI Group Investor Meet on March 6, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 02 Mar 2026, 05:49 PM

Hindustan Unilever Limited (HUL) has informed the exchanges about its upcoming participation in a physical group meeting with the ICICI Group. The meeting is scheduled for March 6, 2026, and will involve management representatives. This disclosure is a routine compliance requirement under Regulation 30 of the SEBI (LODR) Regulations, 2015. Such meetings are standard for large-cap companies to engage with institutional investors and discuss broader business trends.

HUL to attend a physical group meeting with ICICI Group on March 6, 2026.
The meeting will feature participation from HUL's management representatives.
Disclosure made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
This is a routine investor relations event with no immediate financial impact announced.

💡 Investors should monitor for any investor presentations or transcripts that may be released following the meeting for insights into management's outlook. No immediate action is required as this is a standard corporate disclosure.

HUL to Attend Kotak Chasing Growth 2026 Investor Conference on February 25

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 20 Feb 2026, 06:50 PM

Hindustan Unilever Limited (HUL) has announced its participation in the 'Kotak: CHASING GROWTH 2026' investor conference. The meeting is scheduled for February 25, 2026, and will be conducted in a physical format. Management representatives will interact with institutional investors to discuss the company's business environment and strategy. This is a standard regulatory disclosure under SEBI LODR Regulations, 2015, and does not contain any immediate financial updates.

Participation in Kotak: CHASING GROWTH 2026 conference confirmed.
The investor meet is scheduled for February 25, 2026.
The meeting will be held in a physical conference format.
Management representatives will lead the interaction with institutional investors.
Disclosure made in compliance with SEBI Listing Obligations and Disclosure Requirements.

💡 Investors should monitor for any investor presentations or transcripts released after the conference for insights into HUL's growth outlook and margin guidance. No immediate action is required as this is a routine investor interaction.

HUL to Invest ₹2,000 Crore to Expand Premium Manufacturing Capacity

🟢 POSITIVE ⭐ 8/10

EXPANSION 📅 18 Feb 2026, 07:11 PM

Hindustan Unilever (HUL) has announced a strategic investment of ₹2,000 crore to be deployed over the next two years. This capital expenditure is focused on expanding manufacturing capacity for high-growth premium categories within Beauty & Wellbeing and Home Care liquids. The initiative aims to modernize the supply chain through automation and digital technologies while targeting 100% renewable energy for the new facilities. This move underscores HUL's commitment to premiumization and scaling high-margin segments to meet evolving consumer demands.

Proposed investment of ₹2,000 crore over a two-year period across multiple locations.
Focus on premium Skin Care, Hair Care, and Home Care liquid categories.
Capacity expansion to leverage advanced automation and digital technologies for supply-chain agility.
New facilities designed to operate on 100% renewable energy in line with sustainability goals.

💡 Investors should view this as a positive long-term indicator of HUL's focus on high-margin premium segments. Monitor the progress of this capex and its eventual impact on volume growth and operating margins.

HUL Completes Acquisition of Remaining 49% Stake in Zywie Ventures for INR 824 Crores

🟢 POSITIVE ⭐ 8/10

M&A 📅 13 Feb 2026, 02:17 PM

Hindustan Unilever Limited (HUL) has successfully completed the acquisition of the balance 49% stake in Zywie Ventures Private Limited. The transaction was finalized for a total consideration of INR 824 Crores, following the terms of the Share Subscription and Share Purchase Agreement. This move gives HUL full ownership of the entity, which is known for its health and wellness brand OZiva. The acquisition aligns with HUL's long-term strategy to scale its presence in the high-growth digital-first wellness segment.

Acquisition of the remaining 49% stake in Zywie Ventures Private Limited completed on February 13, 2026.
Total cash consideration for the final tranche of shares is INR 824 Crores.
Zywie Ventures becomes a wholly-owned subsidiary of Hindustan Unilever Limited.
The transaction was executed in accordance with the Share Subscription and Share Purchase Agreement dated February 12, 2026.

💡 Investors should view this as a positive consolidation of HUL's portfolio in the premium wellness category. Monitor the integration of Zywie's brands and their impact on HUL's overall margin profile in the coming quarters.

HUL Subsidiary Kwality Wall’s (India) to List 234.96 Cr Shares on Feb 16, 2026

🟢 POSITIVE ⭐ 9/10

M&A 📅 13 Feb 2026, 02:07 PM

Hindustan Unilever Limited (HUL) has announced that its subsidiary/demerged entity, Kwality Wall’s (India) Limited (KWIL), has received final listing and trading approvals from both BSE and NSE. A total of 2,34,95,91,262 equity shares of face value ₹1 each will be admitted to dealings. Trading is scheduled to commence on February 16, 2026, under the symbol 'KWIL' on the NSE. This marks the final stage of the Scheme of Arrangement intended to unlock value for HUL shareholders.

Listing and trading approval received for 2,34,95,91,262 equity shares of ₹1 each
Trading of KWIL shares to officially commence on February 16, 2026
Approvals received from both BSE (Notice 20260212-18) and NSE (Ref: NSE/LIST/190)
The listing follows a court-approved Scheme of Arrangement between HUL and KWIL
KWIL will trade under the symbol 'KWIL' on the National Stock Exchange

💡 Investors should track the listing price on February 16 to determine the market valuation of the standalone ice cream business. Existing HUL shareholders who were allotted KWIL shares should hold or trade based on their outlook for the frozen desserts sector.

HUL Releases Audio/Video Recording of Q3 FY26 Earnings Conference Call

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 13 Feb 2026, 09:40 AM

Hindustan Unilever Limited (HUL) has made the audio and video recordings of its earnings conference call for the quarter ended December 31, 2025, available to the public. The call was held on February 12, 2026, following the release of the company's quarterly financial results. This disclosure is a routine compliance requirement under SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations. Investors can access the recording on the company's official website to understand management's commentary on performance and future outlook.

Audio/Video recording of the Q3 FY26 earnings call is now live on the HUL website.
The conference call was conducted on February 12, 2026, following the December 2025 quarter results.
Compliance filing made under Regulation 30(6) of SEBI (LODR) Regulations, 2015.
The recording provides transparency regarding management's discussion with analysts and institutional investors.

💡 Investors should listen to the recording to gain insights into management's views on volume growth, margin pressures, and rural demand trends. No immediate trading action is required based solely on this administrative filing.

HUL Q3 Net Profit Surges to ₹6,603 Cr Driven by ₹4,516 Cr Exceptional Gain

🔵 WATCH ⭐ 9/10

EARNINGS 📅 12 Feb 2026, 10:39 AM

Hindustan Unilever Limited (HUL) reported a 3% YoY increase in revenue from operations at ₹16,197 crore for the quarter ended December 31, 2025. While total net profit jumped to ₹6,603 crore from ₹2,694 crore YoY, this was primarily due to a massive one-time exceptional gain of ₹4,516 crore from discontinued operations. Profit from continuing operations actually saw a decline, falling to ₹2,118 crore compared to ₹2,791 crore in the year-ago period, reflecting margin pressures.

Revenue from operations grew 3.06% YoY to ₹16,197 crore from ₹15,715 crore.
Total Net Profit stood at ₹6,603 crore, significantly boosted by a ₹4,516 crore exceptional credit in discontinued operations.
Profit from continuing operations decreased by 24% YoY to ₹2,118 crore.
Advertising and promotion expenses remained high at ₹1,522 crore to maintain market share.
Basic EPS for the quarter rose to ₹28.12 from ₹11.43 YoY, largely due to the one-time gain.

💡 Investors should discount the massive jump in net profit as it is driven by a one-time exceptional item. Focus on the underlying performance of continuing operations, which shows a decline in profitability despite modest revenue growth.

HUL DQ'25 Results: 4% Volume Growth, Reported PAT Surges 121% on Ice Cream Demerger One-offs

🟡 NEUTRAL ⭐ 9/10

EARNINGS 📅 12 Feb 2026, 10:27 AM

Hindustan Unilever Limited (HUL) reported a steady 4% underlying volume growth and 5% underlying sales growth for the quarter ended December 2025, with turnover reaching ₹16,235 crores. While reported PAT jumped 121% to ₹6,603 crores due to one-off gains from the Ice Cream business demerger, normalized PAT (before exceptional items) grew marginally by 1% to ₹2,562 crores. EBITDA margins saw a 70 bps compression to 23.3% as the company continues to invest in premiumization and digital channels. The company is also restructuring into a 'Unified India' model to enhance agility and speed in decision-making.

Underlying Volume Growth (UVG) stood at 4% and Underlying Sales Growth (USG) at 5% for the quarter.
Reported PAT rose 121% YoY to ₹6,603 Cr, driven by portfolio transformation and the Ice Cream demerger.
Home Care segment achieved its highest-ever market share, with liquids delivering double-digit growth.
EBITDA margin contracted by 70 bps YoY to 23.3%, while EBITDA grew 3% to ₹3,788 Cr.
Board approved acquiring the remaining 49% stake in OZiva and divesting a 19.8% stake in Nutritionalab Pvt. Ltd.

💡 Investors should monitor the impact of the 'Unified India' restructuring on execution speed and the sustainability of volume growth in a dynamic commodity environment. The stock remains a defensive core holding, though margin pressure suggests a balanced near-term outlook.

HUL to Acquire Remaining 49% Stake in OZiva for ₹824 Cr; Divests Nutritionalab Stake for ₹307 Cr

🟢 POSITIVE ⭐ 8/10

M&A 📅 12 Feb 2026, 10:20 AM

Hindustan Unilever (HUL) has announced the full acquisition of Zywie Ventures (OZiva) by purchasing the remaining 49% stake for ₹824 crores, making it a wholly-owned subsidiary. Simultaneously, the company is divesting its 19.8% minority stake in Nutritionalab to USV Private Limited for ₹307 crores. These moves align with HUL's strategy to focus on high-growth 'bigger bets' within the Health & Wellbeing segment. OZiva has demonstrated strong performance, scaling to a projected ₹480 crores in 2025 with a 130% CAGR over the last two years.

Acquisition of balance 49% stake in Zywie Ventures (OZiva) for a cash consideration of ₹824 crores.
Divestment of 19.8% stake in Nutritionalab for ₹307 crores to USV Private Limited.
OZiva's turnover grew significantly from ₹100.07 crores in FY23 to ₹257.67 crores in FY25.
Both transactions are expected to be completed by March 31, 2026, subject to closing conditions.
Post-transaction, OZiva and its subsidiary Zenherb Labs will become wholly-owned subsidiaries of HUL.

💡 Investors should view this as a positive consolidation move that streamlines HUL's Health & Wellbeing portfolio into high-growth brands. Monitor the integration of OZiva and its contribution to HUL's overall margin profile in the coming quarters.

HUL to Acquire Remaining 49% Stake in OZiva for ₹824 Cr; Divests Nutritionalab Stake for ₹307 Cr

🟢 POSITIVE ⭐ 8/10

M&A 📅 12 Feb 2026, 10:18 AM

Hindustan Unilever (HUL) has approved the acquisition of the remaining 49% stake in Zywie Ventures (OZiva) for ₹824 Crores, making it a wholly-owned subsidiary. Simultaneously, the company is divesting its 19.8% minority stake in Nutritionalab to USV Private Limited for ₹307 Crores. This move aligns with HUL's strategy to focus on fewer, bigger bets within the fast-growing Health & Wellbeing segment. OZiva has shown significant growth, with its turnover rising from ₹100.07 Crores in FY23 to ₹257.67 Crores in FY25.

Acquisition of 49% balance stake in Zywie Ventures (OZiva) for a cash consideration of ₹824 Crores
Divestment of 19.8% stake in Nutritionalab to USV Private Limited for ₹307 Crores
OZiva's turnover grew significantly from ₹100.07 Crores in FY23 to ₹257.67 Crores in FY25
Both transactions are expected to be completed by March 31, 2026
Post-acquisition, Zywie and its subsidiary Zenherb Labs will become 100% subsidiaries of HUL

💡 Investors should view this as a positive strategic consolidation in the high-margin health and wellness space. Monitor the integration of OZiva and its impact on HUL's non-traditional FMCG margins over the next few quarters.

HUL Q3 Net Profit Jumps to ₹6,603 Cr on Exceptional Gain; Core Profit Declines 24% YoY

🔵 WATCH ⭐ 9/10

EARNINGS 📅 12 Feb 2026, 10:18 AM

Hindustan Unilever (HUL) reported a consolidated net profit of ₹6,603 crore for Q3 FY26, a significant increase from ₹2,694 crore YoY, primarily driven by a massive one-time exceptional gain of ₹4,516 crore from discontinued operations. However, the performance of continuing operations was weak, with profit falling 24% YoY to ₹2,118 crore due to higher input costs and a ₹576 crore exceptional charge. Revenue growth remained modest at 3% YoY, reaching ₹16,197 crore, reflecting a challenging consumption environment.

Consolidated Net Profit rose to ₹6,603 Cr, boosted by a ₹4,516 Cr gain from discontinued operations.
Revenue from operations grew 3.1% YoY to ₹16,197 Cr from ₹15,715 Cr in the year-ago quarter.
Profit from continuing operations declined 24.1% YoY to ₹2,118 Cr compared to ₹2,791 Cr in Q3 FY25.
Advertising and promotion expenses stood at ₹1,522 Cr, while total expenses rose to ₹13,078 Cr.
EPS for the quarter surged to ₹28.12 from ₹11.43 YoY, though core operational EPS showed a decline.

💡 Investors should look beyond the headline profit figure as it is inflated by a one-time divestment gain. The decline in core operating profit and modest revenue growth suggest margin pressure, making the stock a 'Watch' for signs of volume recovery.

HUL Updates on Kwality Wall's Scheme: Key Management Appointments Announced

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 09 Feb 2026, 02:00 PM

Hindustan Unilever Limited (HUL) has shared a material update regarding its ongoing Scheme of Arrangement with Kwality Wall’s (India) Limited (KWIL). KWIL has designated Vivek Sarbhai, who has over 33 years of experience in the FMCG and logistics sectors, as Senior Managerial Personnel. Additionally, Anand Upadhyay has been appointed as the Chief Investor Relations Officer and Nodal Officer for IEPF matters. These disclosures are mandatory under the SEBI Listing Regulations and follow observation letters issued by the stock exchanges in May 2025.

Vivek Sarbhai designated as Senior Managerial Personnel (SMP) of KWIL effective February 7, 2026
Vivek Sarbhai brings over 33 years of professional experience from FMCG, Healthcare, and Logistics sectors
Anand Upadhyay appointed as Chief Investor Relations Officer for UPSI disclosure and Nodal Officer for IEPF
Disclosure follows NSE and BSE observation letters dated May 14, 2025, regarding the HUL-KWIL Scheme of Arrangement

💡 These are administrative and personnel updates within a subsidiary involved in a corporate restructuring. Investors should monitor the final approval and execution timeline of the HUL-KWIL Scheme of Arrangement.

HUL Schedules Q3 FY2025-26 Earnings Conference Call for February 12, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 04 Feb 2026, 07:17 PM

Hindustan Unilever Limited (HUL) has officially scheduled its earnings conference call for the quarter ended December 31, 2025, for February 12, 2026. The call will be conducted following the Board Meeting where the financial results will be formally approved. This announcement serves as a follow-up to the company's prior communication on January 20, 2026. Investors and analysts can access the dial-in details and presentation materials through the company's dedicated investor relations website.

Earnings conference call for Q3 FY2025-26 set for February 12, 2026.
The call follows the Board Meeting scheduled for the same day to approve results.
Presentation to analysts and investors will be made available post-meeting.
Dial-in details are accessible via HUL's official investor relations portal.

💡 Investors should note the date to track management's commentary on volume growth and margin outlook. No immediate action is required as this is a routine scheduling notification.

View All HINDUNILVR Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Home Care: INR 22,808 Cr (+4.8% YoY); Beauty & Wellbeing: INR 12,821 Cr (+2.1% YoY); Personal Care: INR 9,039 Cr (-2.9% YoY); Foods: INR 15,098 Cr (-0.36% YoY); Others: INR 914 Cr (+15% YoY). Total Turnover for FY25 was INR 60,680 Cr, up 1.85% from INR 59,579 Cr in FY24.

Geographic Revenue Split

Primarily domestic (India) focused; exports and consignment sales contributed INR 914 Cr (1.5% of total turnover) in FY25. Rural demand recovery is cited as a key driver for future volume growth.

Profitability Margins

Operating profit margin remained stable at 22% in FY25. Net profit margin improved from 17.0% to 17.5% in FY25. Return on Net Worth increased from 20.0% to 21.2% YoY.

EBITDA Margin

EBITDA margin for SQ'25 was 23.2%, down 90 bps YoY due to higher business investments. H1 FY26 EBITDA margin was 23%, down 110 bps YoY. FY25 EBITDA was INR 14,289 Cr (+0.7% YoY).

Capital Expenditure

Historical investments in subsidiaries include INR 352 Cr loan to Unilever India Exports and INR 10 Cr to Lakme Lever. Cash management investments in Mutual Funds and T-Bills totaled INR 20,943 Cr as of March 31, 2025.

Credit Rating & Borrowing

Reaffirmed at CRISIL AAA/Stable. Borrowing costs are negligible as the company maintains a Debt-Equity ratio of 0.0 and an interest coverage ratio of 100.5x.

⚙️ Operational Drivers

Raw Materials

Key raw materials include palm oil and its derivatives (for Skin Cleansing), tea and coffee (for Beverages), and chemicals for Skin Care. Commodity price volatility in these areas directly impacts gross margins.

Import Sources

Sourced globally and domestically; specifically mentions PT. Unilever Oleochemical Indonesia as a key related party supplier for raw materials.

Key Suppliers

PT. Unilever Oleochemical Indonesia (UOI) is a major supplier with a shareholder-approved transaction limit of INR 3,000 Cr per financial year for raw materials.

Capacity Expansion

Current capacity not disclosed in MT; however, the company is 'reshaping the portfolio' by accelerating in high-growth demand spaces and demerging the lower-margin Ice Cream business to improve overall EBITDA by 50-60 bps.

Raw Material Costs

Operating costs for FY25 were INR 47,180 Cr (77.7% of turnover). Gross margins improved by ~400 bps in FY24 due to moderating commodity prices, though SQ'25 saw pricing volatility in Skin Cleansing and Beverages.

Manufacturing Efficiency

Return on Capital Employed (ROCE) improved significantly from 96.3% in FY24 to 108.2% in FY25, indicating high capital efficiency.

Logistics & Distribution

Distribution is managed through an extensive network; costs are part of the 'other expenses' which saw phasing impacts in SQ'25.

📈 Strategic Growth

Expected Growth Rate

Growth Strategy

Strategy based on four pillars: market development, premiumization, reshaping the portfolio (e.g., Ice Cream demerger), and channel focus (e-commerce and specialist stores). The demerger is expected to add 50-60 bps to EBITDA margins. Focus on volume-led growth in H2 FY26.

Products & Services

Soaps (Skin Cleansing), Detergents (Home Care), Tea and Coffee (Beverages), Skin Creams (Skin Care), Ketchup and Soups (Foods), and Ice Cream (until demerger).

Brand Portfolio

Lakme, Kwality Wall's, Minimalist, Surf Excel, Rin, Wheel, Dove, Lux, Ponds, Horlicks.

New Products/Services

Minimalist brand (acquired/partnered) delivered strong double-digit growth in H1 FY26. Focus on 'bold launches' in high-growth demand spaces.

Market Expansion

Expanding specialist store presence (cosmetic stores and chemists) and disproportionate investment in e-commerce, where CAC to LTV ratios are closely monitored.

Market Share & Ranking

Market leader in 85% of its business segments; reported gains in turnover-weighted market shares in SQ'25.

Strategic Alliances

Partnership with Minimalist; Material Related Party Transaction agreement with PT. Unilever Oleochemical Indonesia for raw material supply up to INR 3,000 Cr annually.

🌍 External Factors

Industry Trends

FMCG industry is shifting toward premiumization and e-commerce; rural demand is recovering while urban consumption shows some delay in pantry replenishment.

Competitive Landscape

Intensifying competition from both regional players and large FMCG peers; HUL maintains leadership through 'market development' and 'premiumization'.

Competitive Moat

Strong moat derived from market leadership in 85% of portfolio, extensive distribution network, and brand equity (Lakme, Dove, etc.). Sustainable through high ROCE (108.2%) and EVA-focused capital allocation.

Macro Economic Sensitivity

Highly sensitive to rural demand recovery and inflation; easing inflation is expected to support volume growth in FY25.

Consumer Behavior

Consumers delayed pantry replenishment in SQ'25 in expectation of lower shelf prices due to pricing volatility.

Geopolitical Risks

Resolution of prior years' tax matters between UK and Indian tax authorities resulted in a one-off positive impact on PAT in SQ'25.

⚖️ Regulatory & Governance

Industry Regulations

Transitory impact from GST changes noted in SQ'25; compliance with SEBI (SBEB) Regulations for employee share plans.

Environmental Compliance

Integrated Report focuses on Natural, Human, and Social Capital; specific ESG compliance costs in INR are not disclosed.

Taxation Policy Impact

Normalized Effective Tax Rate is 26.6%. H1 FY26 reported ETR was 20.5% due to one-off tax settlements.

Legal Contingencies

Resolution of prior years' tax matters between UK and Indian tax authorities provided a one-off benefit. 92 integrity incidents reported in FY25, resulting in 37 employee terminations.

⚠️ Risk Analysis

Key Uncertainties

Volatility in commodity prices (palm oil, tea) and the pace of rural demand recovery are the primary uncertainties impacting margins and volume growth.